Clinical Trial Update: NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia [Phase 3]

View source ↗

Summary

This clinical trial update indicates that a Phase 3 long-term study of NBI-1117568 for adults with schizophrenia is currently recruiting. No results are reporte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• NBI-1117568

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Schizophrenia | Phase 3 | Status: RECRUITING